JNCE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: JNCE Market Cap History JNCE YTD Return |
JNCE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: JNCE Market Cap History JNCE YTD Return |
JNCE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+9.37% CAGR Mouse over chart for data details
|
JNCE Stock Price Chart |
About Jounce Therapeutics Inc |
Jounce Therapeutics is a clinical-stage immunotherapy company focuses on the treatment of cancer by developing therapies that enable the immune system to attack tumors. Co.'s product candidates include: JTX-8064, an antibody that binds to Leukocyte Immunoglobulin Like Receptor B2; Vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells commonly found in several solid tumors; Pimivalimab, a clinical-stage anti-PD-1 antibody for potential use in combination with its product candidates; and GS-1811, a monoclonal antibody that depletes T regulatory cells in the tumor microenvironment. We show 27 historical shares outstanding datapoints in our coverage of JNCE's shares outstanding history. Understanding the changing numbers of JNCE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like JNCE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching JNCE by allowing them to research JNCE shares outstanding history as well as any other stock in our coverage universe. |
JNCE Current Stock Quote |
Free JNCE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
JNCE Share Performance |
Shares Outstanding Peers |
Jounce Therapeutics (JNCE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
JNJ Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.